Neurosarcoidosis
Pathophysiology, Diagnosis, and Treatment
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 20, 2021
- Accepted in final form July 12, 2021
- First Published October 4, 2021.
Author Disclosures
- Michael J. Bradshaw, MD*,
- Siddharama Pawate, MD (siddharama.pawate{at}vanderbilt.edu),
- Laura L. Koth, MD (laura.koth{at}ucsf.edu),
- Tracey A. Cho, MD (tracey-cho{at}uiowa.edu) and
- Jeffrey M. Gelfand, MD, MAS, FAAN* (jeffrey.gelfand{at}ucsf.edu)
- Michael J. Bradshaw, MD*,
NONE
NONE
NONE
Continuum: lifelong learning in neurology, editorial board member, 1 year
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Siddharama Pawate, MD (siddharama.pawate{at}vanderbilt.edu),
Biogen advisory board Alexion advisory boards
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Biogen Genentech
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Laura L. Koth, MD (laura.koth{at}ucsf.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
MEDIMMUNE, COMMERCIAL
NIH, PI, 2016 AND 2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tracey A. Cho, MD (tracey-cho{at}uiowa.edu) and
(1) DSMB: A Randomized Trial of Combined Albendazole plus Praziquantel for Subarachnoid Cysticercosis of the Sylvian Fissure or the Basal Cisterns; NIH; 2018: $400
NONE
(1) Speaker honorarium, AAN: $1,000 [2019]
(1) Up To Date: $123
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Josalyn Cho (wife) NIH/NIAID K08AI113083 Principal Investigator 2014-2019 (2) Josalyn Cho (wife) NIH/NIAID UH2AI44434 PI 2019-2020 (3) Josalyn Cho (wife) NIH/NHLBI R01HL148758 PI 2020-2025
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jeffrey M. Gelfand, MD, MAS, FAAN* (jeffrey.gelfand{at}ucsf.edu)
DSMB for a National Institutes of Aging funded study.
NONE
NONE
Dr. Gelfand is on the editorial advisory board of Neurology: Neuroimmunology & Neuroinflammation. Dr. Gelfand's spouse is Editor-in-Chief of Headache and previously served on the editorial team of JAMA Neurology.
NONE
Honoraria from Dynamed Plus for editorial review. Dr. Gelfand's spouse has received honoraria from UpToDate.
NONE
Consulting for Biogen. His spouse has received prior consulting fees from Biohaven, Advanced Clinical, Theranica, and Satsuma.
NONE
NONE
NONE
Research support to University of California, San Francisco from Genentech/Roche. His spouse has received grant support from Amgen.
NONE
NONE
PI of an Institutional Clinician Training Award from the National MS Society.
NONE
NONE
NONE
NONE
NONE
Dr. Gelfand has received compensation for medical-legal consulting as an expert witness; his spouse has also received personal compensation for medical- legal consulting as an expert witness.
- From the University of Washington and Billings Clinic, (M.J.B.); Vanderbilt University Medical Center (S.P.), Nashville, TN; Division of Pulmonary and Critical Care (L.L.K.), Department of Medicine, University of California, San Francisco; Division of Pulmonary and Critical Care, Department of Medicine; Univeristy of Iowa (T.A.C.), Iowa City; Department of Neurology (J.M.G.), Division of Neuroimmunology and Glial Biology, University of California, San Francisco.
- Correspondence
Dr. Bradshaw bradshaw.michaelj{at}gmail.com, or Dr. Gelfand jeffrey.gelfand{at}ucsf.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.